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Identification o f  Lutein and Zeaxanthin Oxidation  
Products in Human and M onkey Retinas
Frederick Khachik* Paul S. Bernstein,f and Donita L. Garland%
Purpose. To characterize fully all the major and minor carotenoids and their metabolites 
in human retina and probe for the presence of the oxidative metabolites o f lutein and 
zeaxanthin.
Methods. Carotenoids of a composite of 58 pairs of human retinas and a monkey retina were 
elucidated by comparing their high-performance liquid chromatography (HPLC)-ultravio­
let/visible absorption spectrophotometry (UV/Vis)-mass spectrometry (MS) profile with those 
of authentic standards prepared by organic synthesis.
Remits. In addidon to lutein and zeaxanthin, several oxidation products o f these compounds 
were present in the extracts from human retina. A major carotenoid resulting from direct 
oxidation of lutein was identified as 3-hydroxy-/3,e-caroten-3'-one. Minor carotenoids were 
identified as: 3'-epilutein, e,e-carotene-3,3'-diol, e,e-carotene-3,3'-dione, 3'-hydroxy-e,e-caro- 
ten-3-one, and 2,6-cyclolycopene-l,5-diol. Several of the geometric isomers of lutein and zeax­
anthin were also detected at low concentrations. These were as follows: 9-cis-lutein, 9'-cis- 
lutein, 13-cis-lutein, 13'-cis-lutein, 9-cis-zeaxanthin, and 13-cis-zeaxanthin. Similar results were 
also obtained from HPLC analysis of a freshly dissected monkey retina.
Conclusions. Lutein, zeaxanthin, 3'-epilutein, and 3-hydroxy-/3,e-caroten-3'-one in human retina 
may be interconverted through a series of oxidation-reduction reactions similar to our earlier 
proposed metabolic transfonnation of these compounds in humans. The presence of the direct 
oxidation product of lutein and 3'-epilutein (metabolite of lutein and zeaxandiin) in human 
retina suggests that lutein and zeaxanthin may act as antioxidants to protect the macula against 
short-wavelength visible light. The proposed oxidative-reductive pathways for lutein and zeaxan­
diin in human retina, may therefore play an important role in prevention of age-related macular 
degeneration and cataracts. Invest Ophthalmol Vis Sci. 1997:38:1802-1811.
I n  1945, W ald1 tentatively identified the yellow pig­
m ent in the human m acula as a carotenoid belonging 
to the xanthophyll families in green leaves. For nearly 
40 years, no attem pt was m ade to establish unequivo­
cally the identity o f this carotenoid in the human mac-
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ula, which is still referred to as xanthophyll in many 
ophthalm ology texts. In 1985, for the first time, Bone 
et al2 presented  prelim inary evidence that the hum an  
m acular pigm ent is a m ixture o f lutein and zeaxan­
thin. A few years later, these pigments, which can be 
classified as hydroxycarotenoids with no vitamin A  ac­
tivity, were also detected in the hum an m acula and 
whole retina by H andlem an et al.3 Using high-perfor­
m ance liquid chrom atography (H PLC), Bone et al 
further studied the retinal distribution o f lutein and 
zeaxanthin for 87 donors aged 3 to 95 years.4 The 
lutein:zeaxanthin ratio increased in individual retinas 
from  an approxim ate average o f 1:2.4 in the central 
(0 to 0.25 mm) to m ore than 2:1 in the periphery (8.7 
to 12.2 m m ).4,5
In 1993, Bone et al6 elegantly established the 
com plete identification and stereochem istry o f the hu­
man m acular pigm ent as lutein [(3R,3 'R ,6 'R)-/?,e-car­
1802
Investigative Ophthalm ology & Visual Science, August 1997, Vol. 38, No. 9 
Copyright © Association for Research in Vision and Ophthalm ology
Oxidation Products o f  Lutein-Zeaxanthin in Retina 1803
otene-3,3 'd io l], zeaxanthin [(3R,3 'R)-/5,/?-carotene- 
3,3 'd io l], and wso-zeaxanthin [(3R,3 'S)-/3,/3-carotene- 
3,3 'd iol]. In a case-con trol study published in 1994, 
high consum ption o f fruits and vegetables, rich spe­
cifically in lutein and zeaxanthin, was correlated with 
a lower risk for age-related m acular degeneration 
(AM D ).7 T he results from  this study indicated that the 
persons consum ing green leafy vegetables containing 
high concentration o f lutein (~ 6  m g/d) had 43% 
lower risk o f exudative AM D relative to the subjects 
in the lowest quintile.
During the past 13 years, we have reported on 
detailed qualitative and quantitative distribution o f ca­
rotenoids in fruits, vegetables, and hum an plasma. We 
have shown that although 40 to 50 carotenoids may 
be present in a typical diet for som eone living in the 
U nited States,8,9 only 14 major dietary carotenoids 
have been identified to date in human plasm a.10-12 
A m on g these plasma carotenoids, we identified four 
oxidative metabolites o f lutein and zeaxanthin and, 
for the first time, by conducting several m etabolic 
studies involving humans, established the in vivo oxi­
dation o f these carotenoids.13'14
Several epidem iologic studies suggested that indi­
viduals with low plasma concentrations o f carotenoids 
and antioxidant vitamins are at increased risk for 
AM D .7,15-17 If the antioxidant efficacy o f the most 
abundant carotenoids in the human retina (i.e. lutein 
and zeaxanthin) were established, the results from 
these epidem iologic studies would be easier to inter­
pret. O ne approach to such investigation would in­
volve com plete characterization o f the carotenoids 
(major and minor) in hum an retina. In addition, to 
establish the role o f carotenoids as antioxidants in 
prevention o f AM D, it is essential to search for the 
presence o f the oxidation products o f these com ­
pounds in retina, particularly those o f lutein and zeax­
anthin.
This article reports on identification o f three ma­
jo r  and 11 m inor carotenoids in human retina by 
HPLC-UV/visible absorption spectrophotometry-mass 
spectrom etry (Vis-MS). Several oxidation products o f 
lutein and zeaxanthin not o f dietary origin are am ong 
the newly identified carotenoids.
MATERIALS AND METHODS 
Source and Sample Preparation
D onor hum an eyes were obtained from the National 
Disease Research Interchange (Philadelphia, PA) and 
the M oran Eye Center (University o f Utah, Salt Lake 
City, U T ). They were transported on ice and reached 
us within 36 hours o f death. Procurem ent methods 
for tissues used in this study were hum ane, included 
proper consent and approval, and com plied with the
tenets o f the Declaration o f Helsinki. After the ante­
rior sections were removed, both neural retina and 
retinal pigm ent epithelia were frozen at — 70°C. 
Healthy rhesus monkeys (Macaco, mulatto) 2 to 4 years 
o f age were treated and cared for in accordance widi 
the recom m endations o f the National Institutes o f 
Health Guide for the Care and Use o f Laboratory 
Animals. T h e use o f m onkey retina was approved by 
the National Eye Institute’s Anim al Care and Use 
Com m ittee and the investigation reported here ad­
hered to the AR V O  guidelines for the use, design, and 
the conduct o f experim ents involving animals. A  pair 
o f  freshly dissected m onkey retinas was rem oved im­
m ediately after the animal was killed and stored at 
— 70°C until analysis.
Large-Scale Extraction o f  Human Retina
All extraction, work-up procedures, and analyses were 
conducted under yellow light to prevent photo-isomeriza­
tion and degradation o f carotenoids. For die preparation 
o f the pool, 58 pail’s o f retinas were removed from the 
thawed posterior poles o f eyes by dissection, then com­
bined and transferred to a 250 ml beaker. Tetrahydrofu- 
ran (THF, 200 ml) containing 0.1% butylated hydroxytol- 
uene (BHT) was added and the retinas were extracted 
by sonication at 5°C to 10°C for 30 minutes. The mixture 
was filtered on a Buchner funnel (Whatman Filter Paper 
No. 113, Fairfield, NJ) and the solid materials were ho­
mogenized with THF (100 ml) in a Waring blender at 
5°C to 10°C for 15 minutes and filtered as above. The 
combined filtrate was concentrated using a rotary evapo­
rator at 30°C and die residue (~50  ml) was partitioned 
between 10% sodium chloride (100 ml) and a mixture 
o f hexane : dichloromediane : m edian ol: N,N - diisopro- 
pylethylamine (DIPEA) a t75%:25%:0.25%:0.1% (100 ml, 
HPLC eluent A ) . The organic layer was removed, dried 
over sodium sulfate, and evaporated to dryness. The resi­
due was filtered through 0.45 fim disposable Acrodisc 
polyvinylidene fluoride filter assembly (American Scien­
tific Products, McGraw Park, IL) using approximately 5 
ml o f HPLC eluent A. The solvent was evaporated under 
nitrogen to dryness and eluent A  was added until the 
total volume o f the extract was 3.0 ml; 50 fi\ samples were 
injected on HPLC system one.
Extraction o f  Individual Donor Retinas
Pairs o f retinas from individual donors were placed in 
a 50 ml centrifuge tube and treated with 1 ml o f the 
3 '-ethoxylutein (internal standard) in TH F (0.042 fj.g/ 
ml). T h e tissues were extracted by sonication using 15 
ml o f TH F (0.1% BH T) at 5°C to 10°C for 15 minutes. 
T h e solution was centrifuged at 20,000g  for 5 minutes; 
the extract was transferred to a 100 ml round bottom 
flask. T he tissues were reextracted with TH F twice (2 
X  15 ml) as above. T h e extracts were com bined and 
evaporated to dryness using a rotary evaporator. T he
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residue was transferred to a 5 ml vial containing 1 ml 
o f water using H PLC eluent A  (~ 3  ml). T h e upper 
organic layer was rem oved and filtered through 0.45 
(j,m disposable Acrodisc polyvinylidene fluoride filter 
assembly into a 5-ml graduated micro-sample vial 
(Am erican Scientific Products, M cGraw Park, IL). The 
water layer was washed with eluent A  (1 ml) and the 
upper layer was rem oved, filtered as above, and com ­
bined with the filtrate in the micro-sample vial. T he 
extract was evaporated to dryness under nitrogen and 
the residue was reconstituted in 200 /A o f  eluent A. 
T he vial was centrifuged at 20,000g  to remove the mi­
nor amounts o f white solid particles; 50 fj\ samples 
were injected on H PLC system two.
Extraction o f  Fresh Monkey Retina
A  pair o f  m onkey retinas ( ~ 0.76 g) were extracted 
according to the procedure described above, and the 
final extract was reconstituted in 150 a 50 1^ sample 
was injected on H PLC system two.
Chromatographic Systems
Qualitative H PLC separations o f carotenoids in a con­
centrated and com bined extract from 58 pairs o f  hu­
man retinas were conducted on H PLC system one, 
which was equipped with a photodiode array detector 
and a particle beam mass spectrom eter. Because o f 
the low sensitivity o f the photodiode array detector, 
routine and quantitative H PLC separations o f carot­
enoids in extracts from  individual retinas were con­
ducted on H PLC system two equipped with a conven­
tional photo-m ultiplier detector.
High-Performance Liquid Chromatography 
System One
A  Beckm an m odel 114M solvent delivery system 
equipped with a Beckm an m odel 421 controller (Ful­
lerton, CA) was interfaced into a Hewlett-Packard 
(HP) 1040A  rapid-scanning UV/visible photodiode 
array detector (Fullerton, CA ). T h e data were stored 
and processed by a HP 9000/Series 300 (Chem-Sta- 
tion) com puting system, in com bination with a HP 
m odel 9153B disk drive, color display m onitor, m odel 
35741, and a m odel 7470A  plotter. T he absorption 
spectra o f the carotenoids were recorded between 200 
and 600 nm at a rate o f 12 spectra/m inute. Separa­
tions were carried out on a silica-based nitrile bonded 
(25-cm length X  4.6 mm internal diameter; 5-/zm 
spherical particle) colum n (Regis Chem ical, M orton 
Grove, IL), which was protected with a Brownlee ni­
trile bonded guard cartridge (3-cm length X  4.6 mm 
ID; 5-//m particle size). T he eluent consisted o f an 
isocratic m ixture o f hexane (74.65% ), dichlorom eth- 
ane (25.00% ), m ethanol (0.25% ), and DIPEA 
(0.10% ). T h e colum n flow rate was 0.7 m l/m inute. 
For reproducible separations with this eluent, accu­
rate com position o f each solvent, particularly that o f 
m ethanol, was m aintained by preparing this H PLC 
eluent as needed. This is because o f volatility o f  hex­
ane and dichlorom ethane that may result in gradual 
evaporation o f these solvents when stored in loosely 
capped H PLC containers. T he m onitoring wavelength 
with this eluent was 445 nm.
This H PLC System was interfaced into a Hewlett- 
Packard m odel 5989A  particle beam mass spectrom e­
ter. T he entire eluate from  the H PLC system one was 
allowed to enter the particle beam interface operated 
at a desolvation tem perature o f 45°C. Electron capture 
negative ionization (ECNI) was achieved using m eth­
ane at a pressure o f 0.85 torr and a source tem perature 
o f 250°C. Spectra were collected from  m ass/charge 
100 to 700 using a scan cycle time o f 1.5 seconds.
High Performance Liquid Chromatography 
System Two
System two consisted o f a Beckm an System Gold 
equipped with a solvent M odule 116, program m able 
detector M odule 166 and an autosam pler 507 (cooled 
to 13°C with Haake FX circulatory bath). T he data 
were stored and processed on an IBM Personal com ­
puting System /2  m odel 55SX with a color display 
monitor. Analytical separations with this System were 
carried out with the same colum n and under identical 
H PLC conditions described above.
Carotenoids Standards and Reagents
T he reference sample o f lutein was isolated from  a 
crude saponified extract o f m arigold flowers in a series 
o f sequential solvent washes and extractions followed 
by crystallization according to a patented proced u re.18 
T he isolated lutein samples were further purified by 
preparative H PLC according to our published m ethod 
to remove the m inor quantities (3% to 5%) o f zeaxan­
thin normally present in the extracts from  m arigold 
flowers.19 T h e (3R,3 'R)-zeaxanthin was isolated from 
Lycium Chinese Mill, a Chinese fruit known as “ G uji”  
and was shown to be identical with a synthetic sample 
o f this com pound obtained from  H offm ann LaRoche. 
T he 3-hydroxy-/3,e-caroten-3 '-one10,20 and 3 '-epilut- 
e in 10 were synthesized from  lutein by oxidation with 
nickel peroxide followed by reduction with sodium 
borohydride (NaBH4) according to published proce­
dures. Nickel peroxide hydrate (product no. 36,719­
2) was purchased from  Aldrich Chem ical (Milwaukee, 
WI) and was renewed and activated according to the 
procedure described by Nakagawa et al.21 T he 3'-Hy- 
droxy-e,e-caroten-3-one was synthesized according to 
our published m ethod.10 Lactucaxanthin was isolated 
from  a saponified extract o f Rom aine lettuce and fur­
ther purified by preparative thin layer chrom atogra­
phy (TLC) followed by HPLC. T h e geom etric isomers 
o f lutein (9Z, 9 'Z, 13Z and 13'Z) and zeaxanthin (9Z
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and 13Z) were prepared and purified according to 
our published procedure.19 T he reference sample o f 
2,6-cyclolycopene-l,5-diol was prepared by oxidation 
o f lycopene with m eta-chloroperbenzoic acid followed 
by acidic hydrolysis.22 T he chem ical structures and pu­
rity o f all the synthetic and isolated samples were fur­
ther confirm ed by 'H-nuclear m agnetic resonance 
(NMR) spectroscopy, UV/Vis, and com bined HPLC- 
MS.
Butylated hydroxytoluene and DIPEA were pur­
chased from Aldrich Chem ical Co. (Milwaukee, WI). 
HPLC-grade solvents, acetonitrile, dichlorom ethane, 
hexane, and m ethanol (Baxter Scientific Division, 
McGaw Park, IL) were used without further purifica­
tion.
Preparation o f 3-Ethoxylutein (Internal 
Standard)
T h e 3 '-ethoxylutein was prepared from lutein similar 
to the m ethod o f Liaaen-Jensen and H ertzberg.20 Lu­
tein (100 mg, 0.176 mmol) was dissolved in dichloro­
m ethane (50 ml) and ethanol (30 ml). Dilute hydro­
chloric acid in ethanol (100 ml, 0.5% vol/vol) was 
added dropwise in 10 minutes and the m ixture was 
stirred at room tem perature under an atm osphere o f 
nitrogen for 3 hours. Triethylam ine (2 ml) was added 
and the product was partitioned between dichloro­
m ethane (100 ml) and 10% NaCl solution (150 ml). 
T he organic layer was separated, dried over sodium 
sulfate, and evaporated to dryness under reduced 
pressure. T h e yellow solid (100 mg) was crystallized 
from m ethanol/dichlorom ethane (8/ 1) at —60°C. 
After drying under high vacuum, the yellow crystals 
o f 3 '-ethoxylutein (84 mg, 0.141 mmol, 80%) was 
shown to be pure by HPLC-UV/Vis-MS (eluent A, sys­
tem one); \ milx (HPLC eluent A) = 270, 334, 424, 448 
(main m axim um ), 476 nm; \ in:ix (dichlorom ethane) = 
336, 431.5 , 454.5 (E 1% = 2233), 483.5 nm; MS (ECNI, 
m ethane): m olecular parent anion peak at m /z = 596 
(100%) and an ion peak at m /z = 550 (9%) because 
o f the loss o f ethanol from  the m olecular parent ion 
peak.
Stability Studies With Lutein, 3-Epilutein, and 
Zeaxanthin
Pure samples o f lutein, zeaxanthin, and 3 '-epilutein 
were kept in both crystalline form and also in TH F 
solutions exposed to air and yellow laboratory light 
for 3 days. A t the end o f this period, the standards 
were exam ined by HPLC-UV/Vis-MS to determ ine 
photodegradation and isomerization o f these com ­
pounds.
In a control experim ent, a m ixture o f lutein and 
zeaxanthin in TH F was subjected to all the extraction 
steps o f human retina described earlier and the prod­
uct was m onitored by H PLC to determ ine the stability 
o f these carotenoids.
RESULTS 
Nomenclature
For convenience, the trivial names o f certain carot­
enoids have been used throughout this text. T h e trivial 
and correct systematic names for these carotenoids 
are presented in Table 1. For in-chain geom etrical 
isomers o f carotenoids, the terms all-E and Z, which 
refer to «//-trans and cis isomers o f carotenoids, respec­
tively, should be used instead o f the old nom enclature. 
However, because many readers are m ore familiar 
with the old nom enclature, we have used die terms 
aM-trans and cis throughout this text. T he R and S 
symbols refer to those carotenoids with known con­
figurations. For several o f the oxidative metabolites o f 
lutein and zeaxanthin, the R and S symbols were not 
used because the absolute configurations o f these ca­
rotenoids with two or m ore centers o f chirality are not 
known at present.
Identification o f  Carotenoids in Human and 
Monkey Retinas
T he major carotenoids have been identified as lutein, 
zeaxanthin, and a direct oxidation product o f lutein, 
namely 3-hydroxy-/?,e-caroten-3 '-one. Several oxida­
tion products o f lutein and zeaxanthin and one o f 
lycopene were also am ong the m inor carotenoids. In 
addition, the most com m on geom etric isomers o f lu­
tein and zeaxanthin, (i.e. 9-cis-lutein, 9 '-cis-lutein, 13- 
cis-lutein, 13'-cis-lutein, 9-cis-zeaxanthin, and 13-cis- 
zeaxanthin) which are usually present in serum were 
also detected at low concentrations in retina. Similar 
results were also obtained from  an extract o f  freshly 
dissected m onkey retina. A  typical H PLC profile o f  a 
com bined extract from 58 pairs o f  human retina is 
shown in Figure 1. T he retinas were com bined to ob­
tain sufficient quantity o f the m inor carotenoids for 
detection and identification by HPLC-UV/Vis-MS. 
T he identity o f carotenoids, the UV/visible absorption 
and mass spectral data are shown in Table 1. These 
were identified by com parison o f their H PLC reten­
tion times and U V/Vis and MS data with those o f 
synthetic or isolated reference samples o f carotenoids.
As shown in Figure 1, in addition to lutein (peak
7) and zeaxanthin [mixture o f 3R,3'R- and 3R,3'S,meso- 
zeaxanthin (peak 8)], which were previously identified 
in human retinas,6 a number o f carotenoid oxidation 
products (peaks 1 through 5, and 9) were also present. 
Lactucaxanthin (Fig. 1, peak 6), a dihydroxycarotenoid 
found in Romaine lettuce (Lactuca sativa), was also de­
tected at a low concentration in human retinas. It is 
imperative to point out that the H PLC separation de­
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t a b l e  l. High-Peformance Liquid Chromatography Peak Identification o f Carotenoids in 






1 e, e-Carotene-3,3'-dione 420,442,472 564
2 3'-Hydroxy-e,e-caroten-3-one 422, 442, 472 566, 548(M-H20 )
3 2,6-Cyclolycopene-l ,5-diol 434, 458, 492 570
4 3-Hydroxy-/?,e-caroten-3'-one (424), 448, 476 566, 548(M-H20 )
5 (c i s) -3-Hy d r o xy-/3, e-ca ro te n-3 '-one 
e,e-Carotene-3,3'-diol (lactucaxanthin)
(420), 442, 470 566, 548(M-H20 )
6 416, 442, 470 568, 550(M-H20 )
7 (a/£trans,3R,3'R,6'R)-/0,e-carotene-3,3'-diol [(all- 
trans,3R,3'R,6'R)-lutein]
(424), 448, 476 568, 550(M-H20 )
8 (a//-trans)-/?,/?-carotene-3,3'-diol [(a/krans,3R,3'R)- 
zeaxanthin -1- (all-trans,3R,3'S,meso)- 
zeaxanthin]
(428), 454, 482 568
9 (a/krans,3R,3'S,6'R)-/3,e-carotene-3,3'-diol [(all- 
trans)-3'-epilutein]
(9-cis,3R,3'R,6'R)-Lutein
(424), 448, 476 568, 550(M-H20 )
10 334, (420), 442, 470 —
11 (9'-cis,3R,3'R,6'R)-Lutein 332, (420), 444, 472 —
12 (13-cis)-Lutein+(13'<is)-lutein 334, (418), 440, 468 —
13 (9-cis)-Zeaxanthin 340, (424), 450, 474 —
14 (13-cis)-Zeaxanthin 338, (419), 446, 472 —
Determined by HPLC photodiode array detection-mass spectrometry in the order o f  elution on a nitrile bonded column.
* Common names for certain carotenoids are shown in parentheses, 
f  Values in parentheses represent points o f  inflection.
| The molecular ions appeared as the base peak (100% intensity). In some cases, ions due to the loss o f  H<20  from the molecular 
parent ion (M) could also be observed.
Because o f  the low concentration, the molecular parent ion was not observed.
lutein, 13-cis-lutein, 13'-cis-lutein, 9-cis-zeaxanthin, and 
13-cis-zeaxanthin, is o f particular interest. This is because 
these isomers may be the products o f in vivo photoisom­
erization o f all-trans-lutein and all-trans-zeaxanthin.
T he chem ical structures o f carotenoids and their 
oxidation products are shown in Figure 2. Com pounds
1, 2, and 4 are the products o f oxidation o f all-trans­
lutein and all-trans-zeaxanthin and com pound 3 was 
recently identified as a m etabolite o f lycopen e,14 the 
red pigm ent found in tomatoes and tomato-based 
products. T h e 3 '-epilutein (com pound 9) may also be 
form ed by a sequential oxidation and reduction o f all- 
trans-lutein or double-bond isomerization o f all-trans- 
zeaxanthin. T h e typical carotenoid profiles obtained 
using a sensitive detector on H PLC system two o f ret­
ina extracts from individual donor eyes and that o f a 
monkey are com pared in Figures 3a and 3b, respec­
tively. In these cases, because o f the insufficient quan­
tity o f sample, the H PLC peak identification was ac­
com plished from retention times o f various peaks and 
their chrom atographic coelution with known syn­
thetic standards. A lthough several o f the m inor carot­
enoids identified in the com bined extracts from 58 
pairs o f hum an retinas were not detected in individual 
human and m onkey retinas because o f low concentra­
tions, the general carotenoid profile o f all the retinas 
was similar.
The qualitative and quantitative distribution o f ca-
scribed here did not resolve (3R,3'R)-zeaxanthin and 
(3R,3'S,meso)-zeaxanthin, and both o f these com­
pounds coeluted as peak 8 (Table 1). Therefore, 
throughout this text, unless specified, the term zeaxan­
thin refers to the mixture o f both (3R,3'S,meso)-zeaxan- 
thin and dietary (3R,3'R)-zeaxanthin. Am ong the minor 
carotenoids, the presence o f several geometric isomers 
o f lutein and zeaxanthin, identified as 9-cis-lutein, 9 '-cis-
FIGURE l. High-performance liquid chromatography 
(HPLC) profile of a combined extract from 58 pairs of hu­
man retinas on system one equipped with a photodiode 
array detector and a particle beam mass spectrometer. The 
HPLC peaks of (3R,3'R)-zeaxanthin and (3R,3'S, meso)- 
zeaxanthin are not. resolved and both appear as peak 8. 
Conditions described in text. For peak identification see 
Table 1.




FIGURE 2. Chemical structures of carotenoids and their me­
tabolites identified in human retina. The planar structures 
for compounds 1, 2, 4, and 6 are shown since the absolute 
configuration of these carotenoids with two or more centers 
of chirality is not known. (*) Only the relative but not abso­
lute configuration for 2,6-cyclolycopene-l,5-diol at C-2, C-5, 
and C-6 is known.
rotenoids in 11 human retinas from donors aged 28 
to 89 years and that o f a 3-year-old m onkey are shown 
in Table 2. T he recoveries o f the internal standard, 
3'-ethoxylutein, from various extractions o f individual 
hum an retinas were greater than 95% as determ ined 
from the H PLC peak area o f this com pound before 
and after extraction. T he carotenoid profiles o f all the 
human retinas and that o f one m onkey showed strik­
ing resem blance in that they all contained m oderate 
concentrations o f a direct oxidation product o f lutein, 
namely 3-hydroxy-/?,e-caroten-3 '-one (peak 4, Figs. 1 
and 3, Table 1); this com pound was accom panied by 
m inute quantity o f a cis-isomer. O ther m inor com po­
nents routinely detected in all o f the retinas exam ­
ined, were 3 '-epilutein (peak 9 , Figs. 1 and 3, Table
1) and the cis-isomers o f lutein and zeaxanthin (peaks 
10- 14, Figs. 1 and 3, Table 1).
Stability Studies With Carotenoids
All-trans-lutein, all-trans-zeaxanthin, and all-trans-3 '- 
epilutein (peaks 7, 8, 9 respectively, Fig. 1, Table 1) 
were found to be stable and did not undergo stereo- 
isomerization or oxidation under the conditions em­
ployed for the extraction o f retina. Similarly, exposure 
o f the pure samples o f these carotenoids both in crys­
talline form  and in TH F solutions to air and yellow 
laboratory lights after 3 days did not result in the con­
version o f these com pounds to the oxidation products 
identified in retina. However, after 3 days, approxi­
mately 10% o f these carotenoids in both crystalline 
form and TH F solutions underwent in-chain oxidative 
cleavage and degradation to give a num ber o f carot­
enoid aldehydes known as apocarotenals. These apo- 
carotenals were not detected in any o f the human or 
the m onkey retina exam ined in the current study.
DISCUSSION
A m ong all the carotenoids identified in hum an retina, 
only (all-trans,3R,3 'R ,6 'R)-lutein, (all-trans,3R,3 'R)-
FIGURE 3. High-performance liquid chromatography (HPLC) 
profiles of retina extracts on system two. (A) a pair of retinas 
from one human subject. (B) a pair of retinas from a monkey. 
Conditions described in text. HPLC peak identification (Table 
1) was based on co-chromatography with synthetic standards.
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t a b l e  2. Carotenoids and Their Oxidation Products Per Two Retinas From 11 Humans and 
One Monkey for Comparison
Human Subjects 

























Carotenoids (peaks) (ng) Concentration (ng/2 retinas)
fl/krans-lutein (7) 37.2 84.5 37.6 22.7 52.3 24.8 199 62.2 236 112 388 58.7
Total cis-luteins
(10-12) 4.6 5.9 3.8 2.4 5.5 3.0 35.0 6.3 13.6 10.5 36.3 5.6
«//-trans-lutein +
cis-luteins 41.8 90.4 41.4 25.1 57.8 27.8 234 68.5 250 123 424 64.3
w/krans-
zeaxanthin (8) 21.7 96.3 31.9 23.3 48.3 15.2 117 49.7 155 75.3 254 35.4
Total cis-
zeaxanthins
(13-14) 4.9 15.0 5.2 3.0 5.2 4.0 35.3 10.5 24.9 7.2 46.1 8.8
a/krans-zeaxanthin
+ cis-zeaxanthins 26.6 111 37.1 26.3 53.5 19.2 152 60.2 180 82.5 300 44.2
all- trans + cis-3-
hydroxy-/3,e-
caroten-3'-one
(4-5) 5.6 21.6 11.3 9.8 17.7 8.1 96.2 15.6 63.8 53.9 94.9 28.4
rt/krans-3'-
epilutein (9) 0.7 5.6 1.5 2.6 2.6 1.3 15.5 3.7 7.7 6.5 20.7 5.2
Ratio o f  Concentrations
all-trans lutein/
total cis-luteins 8.0 14.3 9.9 9.5 9.5 8.3 5.7 9.9 17.4 10.7 10.7 10.5
«//-trans
zeaxanthin/total
cis-zeaxanthins 4.4 6.4 6.1 7.8 9.3 3.8 3.3 4.7 6.2 10.5 5.5 4.0
Total-lutein/total-
zeaxanthin 1.6 0.8 1.1 1.0 1.1 1.5 1.5 1.1 1.4 1.5 1.4 1.5
zeaxanthin, all-trans-lactucaxanthin, and their cis-geo­
m etric isomers are o f dietary origin. A lthough 
(3R,3 'R ,6 'R)-lutein is the most abundant carotenoid 
in all green and some yellow fruits and vegetables, the 
dietary sources o f (3R,3 'R)-zeaxanthin are limited to 
corn, peaches, certain varieties o f squash, and citrus 
fruits.8 Similarly, am ong all the com m only consum ed 
fruits and vegetables in the U.S., only Rom aine lettuce 
had m oderate concentrations o f lactucaxanthin (un­
published results, 1995).
T h e presence o f the oxidation products o f lutein 
and zeaxanthin in hum an retinas (peaks 1 through 5 
and 9 , Fig. 1) was at first treated with a great deal o f 
caution because in some cases the retina samples did 
not reach the laboratory until 36 hours after death. 
A lthough upon collection, these samples were stored 
on ice, there was always the possibility that oxidation 
o f lutein and zeaxanthin may have occurred in retina 
after the removal o f the eyes. However, when a fresh 
pair o f retina from  a 3-year-old Rhesus m onkey was 
extracted and analyzed by HPLC, the presence o f a
direct oxidation product o f lutein, nam ely 3-hydroxy- 
/?,e-caroten-3 '-one (com pound 4, Fig. 2) and 3 '-epilut- 
ein (com pound 9, Fig. 2) was established unequivo­
cally. In addition, the results from  stability studies have 
clearly indicated that the oxidation products o f lutein 
and zeaxanthin identified in the human and m onkey 
retina are not artifacts o f storage, handling, and ex­
traction.
These carotenoid oxidation products are not o f 
dietary origin and have previously been identified in 
human plasma and breastmilk by Khachik et al.10-12 
It is not known if these carotenoid oxidation products 
are transported to and accum ulated in retina via the 
circulatory system or w hether photo-induced meta­
bolic oxidation o f lutein and zeaxanthin may be re­
sponsible for their presence. It is im portant to note 
that all o f  these oxidation products are present in both 
human plasma and retinas at very low concentrations. 
However, only the direct oxidation product o f lutein, 
3-hydroxy-/3,e-caroten-3 '-one, is found in the retina at 
relatively high concentrations com pared with other



















FIGURE 4. Proposed metabolic transformations of dietary 
(3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in human ret-
oxidative metabolites o f carotenoids. Currently, this 
finding provides the only evidence for a possible in 
vivo m etabolic oxidation o f lutein in hum an retina. 
T he protection o f retina from short-wavelength visible 
light by lutein and zeaxanthin is based on two assump­
tions. First, the oxidation products o f lutein and zeax­
anthin are form ed in vivo in the retina. Second, these 
oxidative metabolites are form ed by the action o f blue 
light. Based on several supplem entation studies with 
purified lutein and zeaxanthin involving hum an sub­
jects, we proposed m etabolic pathways for conversion 
o f  these dietary carotenoids to their oxidation prod­
ucts.1314
A ccordin g to these m etabolic transformations, 
(3R,3 'S,m eso)-zeaxanthin, (3R,3 'R ,6 'R)-lutein, and 
(3R,3 'R)-zeaxanthin may be inter-converted through 
a series o f oxidation-reduction and double bond isom­
erization reactions, as shown in Figure 4. T he driving 
force for the direct oxidation o f lutein to 3-hydroxy- 
/?,e-caroten-3 '-one is the activation o f the hydroxyl 
group at C-3 ' by the neighboring allylic double bond. 
However, in (3R,3 'R)-zeaxanthin, because o f the non- 
allylic nature o f the hydroxyl groups at C-3 and C- 
3 ', this com pound is not directly oxidized and may 
therefore undergo double bond isomerization to yield 
3 '-epilutein [(3R,3 'S ,6 'R)-lutein] before oxidation. As 
a result, 3-hydroxy-/?,e-caroten-3 '-one can also be 
form ed from allylic oxidation o f 3 '-epilutein. T o  estab­
lish inter-conversion between carotenoids in these 
m etabolic transformations, once 3-hydroxy-/?,e-caro- 
ten-3 '-one is form ed it may undergo reduction reac­
tions with epim erization at C-3 ' to yield lutein and/ 
or 3'-epilutein. In another double bond isomerization 
reaction, dietary (3R,3 'R ,6 'R)-lutein may be trans­
form ed into (3R,3'R,w6y0)-zeaxanthin (Fig. 4). The 
presence o f (3R,3 'S,ragso)-zeaxandiin and die stereo­
chemistry o f the m acular carotenoids in humans has 
been elegandy established by Bone et al.6
We have determined recendy that 98% o f zeaxanthin 
in human plasma is in the form o f dietary (3R,3'R)-zeax­
anthin and only 2% exists as ( 3R,3'R,meso)-zeaxandiin 
(unpublished results, 1995). Therefore, the fact diat Bone 
et al6 have demonstrated that almost equal amounts o f 
(3R,3'R)-zeaxanthin and (3R,3'R,?mo)-zeaxanthin are 
present in the human macula indicates that the latter 
compound may be formed from double bond isomeriza­
tion o f dietary (3R,3'R,6'R)-lutein as shown in Figure
4. Unfortunately, the only evidence in support o f these 
metabolic transformations is the mere presence o f 3-hdyr- 
oxy-/?, e-caro ten-3'-one, 3'-epilutein, and meso-zeaxanthin 
in the retina. The transport and the metabolic intercon­
versions between lutein and the two forms o f zeaxanthin 
in human retinas are most probably induced by die radia­
tion from short-wavelength visible light, catalyzed by cer­
tain proteins, or both. It is known that human macular 
carotenoids bind to retinal tubulin,23 and other more 
specific human macular carotenoid binding proteins are 
being identified and characterized (Bernstein et al, un­
published results, 1996).
T he concentrations o f the cis/trans stereoisomers 
o f lutein, zeaxanthin, and several o f dieir prom inent 
oxidation products in retinas from  11 hum an subjects 
and in one m onkey don or are shown in Table 2. From 
these data, it appears that the concentration o f carot­
enoids and their m etabolites vary over a wide range 
for all subjects regardless o f age group. Particularly 
noticeable is the relatively high concentrations o f the 
total 3-hydroxy-/?,e-caro ten-3 '-one (trans + cis), which 
range from  8 ng to 96 ng and appear to increase nearly 
proportionally with lutein concentrations. T h e ratio 
o f concentration o f the total lutein (trans + cis) to 
total zeaxanthin (trans + cis) in the whole retina varies 
from  0.8 to 1.5 , but it is generally in favor o f lutein 
for nearly all subjects. However, it must be noted that 
Bone et al4,0 dem onstrated that, in individual retinas, 
the lutein:zeaxanthin ratio increased from  an average 
o f approxim ately 1:2.4 in the central 0 mm to 0.25 
mm to over 2:1 in the periphery (8.7 mm to 12.2 
m m). O n the other hand, depending on the diet o f 
an individual, the concentration o f lutein (trans + 
cis) in plasma may be as high as 9 times that o f zeaxan­
thin (trans + cis).12 This is reflective o f the m uch lower 
dietary distribution o f (3R,3 'R)-zeaxanthin relative to 
(3R,3 'R ,6 'R)-lutein.
However, by considering that almost 50% o f total 
zeaxanthin in the hum an retina is in the form o f 
(3R,3 'S,m£so)-zeaxanthin,6 which is not dietary' and
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presumably form ed from  m etabolic transformation o f 
dietary (3R,3 'R ,6 'R)-lutein, one may explain the un­
usual difference between the ratio o f lutein:zeaxan- 
thin in plasma versus retina. It is im portant to note 
that the quantitative data presented in Table 2 are 
from pairs o f retinas pooled from  individual donors 
and therefore these concentrations do not account 
for pigm ent variation between left and right eye. Bone 
et al dem onstrated that pigm ent variations between 
left and right eye may range from 0 to 43% and averag­
ing 13 ± SD 10%.4
As shown in Table 2, the cis-isomers o f lutein and 
zeaxanthin are also present in the hum an retina at low 
concentrations relative to their all-trans com pounds. It 
is likely that these cis-isomers may be form ed as a 
result o f in vivo photo-induced stereo-isomerization o f 
all-trans-lutein and all-trans-zeaxanthin in the retina 
because this is one o f the most com m on reactions 
observed with carotenoids. A nother likely source o f 
the cis-isomers o f lutein and zeaxanthin may be hu­
man plasma where we have previously identified the 
geom etric isomers o f these com pounds.10" 12,19
CONCLUSION
T he detection o f the oxidation products o f lutein and 
zeaxanthin in the human retina supports the hypothe­
sis that dietary (3R,3 'R ,6 'R)-lutein and (3R,3 'R)-zeax­
anthin may act as antioxidants to protect the retina 
from  over exposure to the short-wavelength visible 
light. Lutein and zeaxanthin were also recendy identi­
fied in the hum an lenses and may also play a role in 
prevention o f cataracts.24 Therefore, the presence o f 
these com pounds in the retina and lens at reasonably 
high concentrations may be essential to prevent macu­
lar degeneration and cataracts. This hypothesis is fur­
ther supported by the established role o f carotenoids 
in green plants; where lutein is the most abundant 
com ponent and, along with other carotenoids, pre­
vents the destruction o f chlorophylls from  over expo­
sure to sunlight. In addition, am ong the 14 dietary 
carotenoids routinely detected in hum an plasma, only 
lutein and zeaxanthin appear to accum ulate in the 
human retina at m uch higher concentrations than 
other equally prom inent carotenoids such as lyco­
pene, a-carotene, and /0-carotene.
O ne explanation may be that there are certain 
structural requirem ents such as the presence o f the 
two hydroxyl groups in lutein and zeaxanthin, because 
these com pounds are the only two dihydroxycarot- 
enoids in com m only consum ed fruits and vegetables. 
A ccordin g to a recently published epidem iologic 
study, high consum ption o f fruits and vegetables spe­
cifically rich in lutein and zeaxanthin may lower the 
risk for m acular degeneration.7 Clinical intervention 
trials with purified supplem ents o f lutein and zeaxan­
thin involving patients at an early stage o f macular 
degeneration will be necessary to determ ine the effi­
cacy and effectiveness o f these com pounds in m ainte­
nance and treatm ent o f this disease. Currently, lutein 
is routinely isolated and purified com m ercially from 
extracts o f m arigold flowers ( Tagetes erecta) according 
to a U.S. Patent18 and is readily available whereas the 
large scale isolation and production o f zeaxanthin 
from  natural sources is still under developm ent.
Key words
carotenoid oxidation products, 3'-epilutein, high-perfor­
mance liquid chromatography-mass spectrometry, 3-hy­
dro xy-/3, e-ca ro te n-3' -o n e , lutein, new carotenoid metabo­
lites, zeaxanthin
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